These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Prospects for xenotransplantation of the liver. Kanazawa A; Platt JL Semin Liver Dis; 2000; 20(4):511-22. PubMed ID: 11200419 [TBL] [Abstract][Full Text] [Related]
28. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Nagata H; Ito M; Cai J; Edge AS; Platt JL; Fox IJ Gastroenterology; 2003 Feb; 124(2):422-31. PubMed ID: 12557148 [TBL] [Abstract][Full Text] [Related]
29. Present status and perspectives of cell-based therapies for liver diseases. Nussler A; Konig S; Ott M; Sokal E; Christ B; Thasler W; Brulport M; Gabelein G; Schormann W; Schulze M; Ellis E; Kraemer M; Nocken F; Fleig W; Manns M; Strom SC; Hengstler JG J Hepatol; 2006 Jul; 45(1):144-59. PubMed ID: 16730092 [TBL] [Abstract][Full Text] [Related]
31. Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Chan C; Berthiaume F; Nath BD; Tilles AW; Toner M; Yarmush ML Liver Transpl; 2004 Nov; 10(11):1331-42. PubMed ID: 15497161 [TBL] [Abstract][Full Text] [Related]
32. Treatment of nonalbumin rats by transplantation of immortalized hepatocytes using artificial human chromosome. Ito M; Ikeno M; Nagata H; Yamamoto T; Hiroguchi A; Fox IJ; Miyakawa S Transplant Proc; 2009; 41(1):422-4. PubMed ID: 19249570 [TBL] [Abstract][Full Text] [Related]
33. Hepatocyte transplantation for acute and chronic liver diseases. Méndez-Sanchez N; Chávez-Tapia NC; Uribe M Ann Hepatol; 2005; 4(3):212-5. PubMed ID: 16184632 [TBL] [Abstract][Full Text] [Related]
34. Life support of artificial liver: development of a bioartificial liver to treat liver failure. Kobayashi N J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648 [TBL] [Abstract][Full Text] [Related]
36. Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Oertel M; Rosencrantz R; Chen YQ; Thota PN; Sandhu JS; Dabeva MD; Pacchia AL; Adelson ME; Dougherty JP; Shafritz DA Hepatology; 2003 May; 37(5):994-1005. PubMed ID: 12717380 [TBL] [Abstract][Full Text] [Related]
37. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Soto-Gutiérrez A; Kobayashi N; Rivas-Carrillo JD; Navarro-Alvarez N; Zhao D; Okitsu T; Noguchi H; Basma H; Tabata Y; Chen Y; Tanaka K; Narushima M; Miki A; Ueda T; Jun HS; Yoon JW; Lebkowski J; Tanaka N; Fox IJ Nat Biotechnol; 2006 Nov; 24(11):1412-9. PubMed ID: 17086173 [TBL] [Abstract][Full Text] [Related]
38. Isolation of a bone marrow-derived stem cell line with high proliferation potential and its application for preventing acute fatal liver failure. Miyazaki M; Hardjo M; Masaka T; Tomiyama K; Mahmut N; Medina RJ; Niida A; Sonegawa H; Du G; Yong R; Takaishi M; Sakaguchi M; Huh NH Stem Cells; 2007 Nov; 25(11):2855-63. PubMed ID: 17702985 [TBL] [Abstract][Full Text] [Related]
39. Cryopreservation of isolated human hepatocytes for transplantation: State of the art. Terry C; Dhawan A; Mitry RR; Hughes RD Cryobiology; 2006 Oct; 53(2):149-59. PubMed ID: 16793034 [TBL] [Abstract][Full Text] [Related]
40. Establishment of a tightly regulated human cell line for the development of hepatocyte transplantation. Kobayashi N; Noguchi H; Watanabe T; Matsumura T; Totsugawa T; Fujiwara T; Westerman K; Leboulch P; Fox IJ; Tanaka N Hum Cell; 2000 Mar; 13(1):7-13. PubMed ID: 10937342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]